The development of aptamer-based electrochemical biosensors as an emerging technology has
made the detection of small and macromolecular analytes easier, faster, and more suited for
early detection of protein biomarkers. Biomarkers are produced by body organs or tumors and
measure antigens on cell surfaces. When detected in high amounts in blood, they can be
suggestive of tumor activity 1,2. These markers are more often used to evaluate treatment
effects or to assess the potential for metastatic disease in patients with established disease.
Osteopontin (OPN) is a protein found in all body fluids, and constitutes a possible biomarker
because its overexpression has been related with breast cancer evolution and metastasis 3–5.
Currently, biomarkers are commonly used for the development of diagnostic methods,
allowing the detection of the disease in its initial stages. An electrochemical aptasensor for the
detection of OPN was developed using an RNA aptamer immobilized on a gold screenprinted
electrode (Au/SPE). The immobilized biotin-modified aptamer on Au/SPE constitutes
the biorecognition element for the target protein and the electrochemical signal generated
from the interaction aptamer-target protein was evaluated by cyclic voltammetry (CV). A
decrease in the current as a consequence of protein binding to the aptamer was observed
through the analysis of the electron flow produced by a redox reaction between ferri- and
ferrocyanide. The electrochemical aptasensor herein developed presents a high specificity for
OPN as compared with other proteins commonly found in the biological fluids
